Plenaxis (abarelix), a new drug for advanced prostate cancer

Some men will be put on Plenaxis (abarelix), a new drug for advanced prostate cancer.

Plenaxis suppresses testosterone by blocking gonadotropin- releasing hormone receptors. It doesn't cause an initial testosterone surge...like Lupron and other gonadotropin agonists.

But Plenaxis has a serious drawback...it causes life-threatening allergic reactions in almost 4% of patients.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber's Letter includes:

  • 12 issues every year, with brief articles about new meds and guidelines
  • 48+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote